Lorazepam Concentrate
Product Images NDC 62135-549

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 62135-549). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Lorazepam Oral Concentrate Label)

Image Description (Lorazepam Oral Concentrate Label)
Lorazepam 2 mg/mL oral concentrate label from Chartwell RX, LLC. The 30 mL bottle label includes dosage strength, NDC 62135-549, storage instructions between 20°C to 25°C, and a medication guide URL. Marked Rx only with measures in mL on the left side and a barcode on the right. The label instructs to protect from light and keep out of reach of children.*
FDA Label Image

Image Description (Lorazepam Structure)

Image Description (Lorazepam Structure)
Chemical structure diagram of Lorazepam showing its benzodiazepine core with chloro-substituted aromatic rings and a lactam group. The illustration depicts key functional groups including amide and hydroxyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.